Follow the Vector Science and Therapeutics Corp. (formerly OpenSesame Acquisition Corp.) share price and the full directors' dealings record of the company, a listed equity based in Canada. Shares are quoted on the CA market, under the authority of SEDI. Market capitalisation: €339.3m. The latest transaction was filed on 2 September 2026 (11 - Acquisition or disposition carried out privately). Among the most active insiders: Kelly, Scott. All data is openly available.
14
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
31Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,423 of 29,063 companies
35.6
score / 100
Value
34
Quality
37
FCF yld-0.2%
Earn yld-0.3%
EV/EBITDA·
ROE-104%
Gross mgn67%
Net mgn-0.0%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
68,870 shares@ CA$1.69100.0% of flowOptionsTSXSEDI:4727951
14 of 14 declarations
Acerca de Vector Science and Therapeutics Corp. (formerly OpenSesame Acquisition Corp.)
Vector Science and Therapeutics Corp. es una empresa de biotecnología centrada en el desarrollo de terapias innovadoras. Anteriormente conocida como OpenSesame Acquisition Corp., opera en el mercado XTSE.